What is Prodo Laboratories?
Prodo Laboratories, Inc. is a specialized service company dedicated to supplying high-quality human and animal islets, crucial for diabetes research. Established in 2006, the company collaborates with the Scharp-Lacy Research Institute to offer comprehensive services including islet isolations, assays, and project-based consulting. Their primary offerings, human islets for research, are vital for biotechnology and pharmaceutical firms engaged in drug development and the study of insulin-producing cells. Prodo Labs is committed to enhancing islet isolation efficiency and fostering broader collaborations within the global diabetes research sector.
How much funding has Prodo Laboratories raised?
Prodo Laboratories has raised a total of $374K across 2 funding rounds:
Debt
$150K
Debt
$224K
Debt (2020): $150K with participation from PPP
Debt (2021): $224K led by PPP
What's next for Prodo Laboratories?
With the recent large-scale, late-stage funding, Prodo Laboratories is strategically positioned for significant expansion and operational enhancement. This substantial capital injection is expected to fuel advancements in their islet isolation technologies and broaden their research support services. The company's focus on critical diabetes research indicates a trajectory aimed at accelerating therapeutic discoveries and improving patient outcomes. Future developments will likely involve scaling their capacity to meet the increasing demand from pharmaceutical and biotech partners, further solidifying their position as a key enabler in the fight against diabetes.
See full Prodo Laboratories company page
